Welcome to the Fellowship Program in Hematology and Medical Oncology at the University of Illinois at Chicago. Our program is dedicated to offering our patients compassionate and competent care while providing fellows with a state-of-the-art medical education.
Fellows have the opportunity to work with patients from a wide variety of racial, ethnic, and socio-economic backgrounds. Our institution emphasizes the need to overcome healthcare barriers and reduce disparities between different socio-economic levels of patients and we accomplish this mission by delivering quality care to all individuals.
We are currently only able to consider residents who are in ABIM approved residencies in US Hospitals. If applicants are not permanent US residents, they must already have an appropriate VISA that will permit them to stay in the US for the three-year training period. This is usually called a J Visa.
Fellows may pursue training in either clinical or basic type research that pertains to the discipline of Hematology or Medical Oncology. All research must be pursued with the supervision of a specified faculty mentor who agrees to the fellow’s participation and accepts responsibility for the fellow’s research training. In general, fellows are encouraged to primarily establish relationships with clinical or basic researchers within the Section of Hematology/Oncology. However, requests to pursue work with other investigators at the University of Illinois or outside institutions will be considered on a case-by-case basis. Fellows should seek to define a research interest early in their training and identify an appropriate mentor before the end of their first year of training.
The Hematology and Medical Oncology Fellowship at the University of Illinois in Chicago is an urban-based, three year, ACGME-accredited training program.
Our program serves a highly diverse multi-ethnic and multicultural patient population that encompasses all socioeconomic strata.
Training tracts are flexible and tailored to individual trainee’s goals and aspirations with exciting opportunities to pursue research projects through our phase 1 clinical trial program, our pioneering stem cell transplant program, our precision medicine and in-house tumor sequencing program and our rigorous quality improvement program.
The program offers a specially mentored tract for physician-scientists (7 year program), extra training in stem cell transplantation (one year, non-certified) and concurrent training opportunities through our school of public health (MPH).
Our division is also actively pursuing Global Health initiatives in Nepal, Ukraine, India and Nigeria which we hope to parlay into training and research opportunities for fellows in the near future.
To train highly competent, caring and cutting-edge specialists who are able to apply and advance the state of the art with confidence and autonomy.
To provide a training environment that fosters inquiry and the highest standards of evidence-based medicine in service to the care of patients with hematological and oncological disorders.
To teach trainees the fundamental principles of humane and compassionate medical care for all patients regardless of race color creed or economic status.
To ensure acquisition of analytical and practical skills needed to advance the state of the art through research and academic endeavors.
To promote and ensure the highest ethical standards of professional conduct of all trainees.